Is the British Gas boss really worth £8.2m? | Nils Pratley
TAstraZeneca caused an uproar when it proposed to pay its chief executive, Pascal Soriot, £18.7 million if he met performance targets, sparking a 35% backlash from shareholders. The defence argument was that the drug company was one of the largest in the FTSE 100 index and had to compete for executives in the US, where […]